Sam J. Lehman

Learn More
Bivalirudin is a member of the direct thrombin inhibitor group of anticoagulants. It has been evaluated as an alternative to unfractionated and low-molecular-weight heparins in the settings of percutaneous coronary intervention (PCI) and acute coronary syndrome (ACS). Results of clinical trials to date suggest bivalirudin is a viable alternative to the use(More)
A 54 year old female with history of hypertension, hyperlipidemia and family history of coronary artery disease (CAD) presented to the emergency department (ED) with chest pain. Symptoms were intermittent, left anterior chest pain similar to past episodes, more intense around the left shoulder and mid back, radiating to the anterior chest. Her pain was(More)
  • 1